drugset / Trial / NCT04257032
A Study in Healthy Men to Test the Influence of BI 1323495 on the Amount of the Medicines Rosuvastatin and Dabigatran in the Blood
RandomizedCrossoverOpen-labelTreatment
Summary
The main objectives of this trial are to investigate the relative bioavailabilities of rosuvastatin (Reference 1, Part 1) and dabigatran (Reference 2, Part 2) given alone and together with BI 1323495 (Test 1, Test 2) following oral administration.
Timeline
- Start
- 2020-02-13
- Primary completion
- 2020-09-23
- Completion
- 2020-09-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 1323495 | Unknown | — | Oral |
| Subject | Dabigatran etexilate | Unknown | — | Oral |
| Subject | Rosuvastatin | Small molecule | — | Oral |
Indications
No indication recorded.